![Dana Levasseur](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Perfil
Dana Levasseur worked as a Director at Bioverativ, Inc. from 2017 to 2018 and as a Vice President-Haematology at Beam Therapeutics, Inc. from 2018 to 2020.
He holds a doctorate degree from The University of Alabama at Birmingham.
Antiguos cargos conocidos de Dana Levasseur.
| Empresas | Cargo | Fin |
|---|---|---|
| BEAM THERAPEUTICS INC. | Corporate Officer/Principal | 01/04/2020 |
| BIOVERATIV INC | Director/Miembro de la Junta | 01/06/2018 |
Formación de Dana Levasseur.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
11
Relaciones de 1er grado
3
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
The University of Alabama at Birmingham
 The University of Alabama at Birmingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bioverativ, Inc.
 Bioverativ, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that engages in discovery, research, development and commercialization of therapies for hemophilia & blood disorders | Health Technology |
Beam Therapeutics, Inc.
 Beam Therapeutics, Inc. BiotechnologyHealth Technology Operate as a biotechnology company that develops precision genetic medicines, gene editing and delivery technologies | Health Technology |
- Bolsa de valores
- Insiders
- Dana Levasseur
